论文部分内容阅读
肺孢子虫肺炎(PCP)是由卡氏肺孢子虫(现称卡氏肺孢子菌或伊氏肺孢子菌)所致的一种机会性感染,其临床表现缺乏特异性,疾病进展快,死亡率高,给临床诊断及治疗带来困难。新型抗真菌药卡泊芬净毒性小,耐受好,成为复方磺胺甲基异噁唑治疗PCP失败或不能耐受者的选择。本文报道卡泊芬净联合治疗1例急性红白血病伴发PCP患者,以期为PCP的治疗提供相关临床经验。
Pneumocystis pneumonia (PCP) is an opportunistic infection caused by Pneumocystis carinii (now known as Pneumocystis carinii or Pneumocystis sp.), Its clinical manifestations are not specific, its disease progresses rapidly, and it dies High rate, to clinical diagnosis and treatment difficulties. The new anti-fungal drug caspofungin is less toxic and tolerated well and has been the compound of choice for sulfamethoxazole in patients with PCP failure or intolerance. This article reports caspofungin combination treatment of 1 case of acute erythroleukemia associated with PCP in order to provide clinical experience for the treatment of PCP.